Učitavanje...
Drug Industry Groups Oppose FDA “Quality Metrics” Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages
Raising their voices in nearly unanimous opposition, pharmaceutical manufacturers and their suppliers have mounted a campaign to dissuade the FDA from launching a voluntary program in 2018 that is aimed at reducing drug shortages.
Spremljeno u:
| Izdano u: | P T |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MediMedia USA, Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5481295/ https://ncbi.nlm.nih.gov/pubmed/28674472 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|